Janus Henderson Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $524K | Hold |
11,100
| – | – | ﹤0.01% | 1927 |
|
2025
Q1 | $442K | Hold |
11,100
| – | – | ﹤0.01% | 2020 |
|
2024
Q4 | $600K | Hold |
11,100
| – | – | ﹤0.01% | 1947 |
|
2024
Q3 | $560K | Hold |
11,100
| – | – | ﹤0.01% | 1980 |
|
2024
Q2 | $487K | Sell |
11,100
-187
| -2% | -$8.21K | ﹤0.01% | 2001 |
|
2024
Q1 | $567K | Buy |
11,287
+65
| +0.6% | +$3.27K | ﹤0.01% | 1945 |
|
2023
Q4 | $677K | Sell |
11,222
-110
| -1% | -$6.64K | ﹤0.01% | 1853 |
|
2023
Q3 | $646K | Buy |
+11,332
| New | +$646K | ﹤0.01% | 1798 |
|
2021
Q4 | – | Sell |
-15,168
| Closed | -$150K | – | 2572 |
|
2021
Q3 | $150K | Sell |
15,168
-33,095
| -69% | -$327K | ﹤0.01% | 2113 |
|
2021
Q2 | $497K | Hold |
48,263
| – | – | ﹤0.01% | 1433 |
|
2021
Q1 | $493K | Sell |
48,263
-101,737
| -68% | -$1.04M | ﹤0.01% | 1355 |
|
2020
Q4 | $1.66M | Buy |
+150,000
| New | +$1.66M | ﹤0.01% | 1152 |
|